Pharmaceuticals, Biotechnology and Life Sciences
LONDON–(BUSINESS WIRE)–#EsophagealCancerDrugsMarketSize–Technavio has been monitoring the global esophageal cancer drugs market since 2018 and the market is poised to grow…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sigilon Therapeutics, Inc., a biotechnology company developing functional cures for chronic diseases through its Shielded Living Therapeutics™ platform,…
– Physician-scientist is an international leader in the field of Obstructive Sleep Apnea pharmacological treatment CAMBRIDGE, Mass.–(BUSINESS WIRE)–Apnimed, a clinical-stage…
BEDFORD, Mass.–(BUSINESS WIRE)–$OCUL #OCUTX–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative…
Nine Abstracts Will Highlight Data Including on the First FDA-Approved Treatment for Peanut Allergy and Oral Immunotherapy Practice Implementation in…
Acquisition will spur the development of new drugs to treat complex neurodegenerative conditions, including Alzheimer’s and Parkinson’s disease PRINCETON, N.J.–(BUSINESS…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Pandion Therapeutics, Inc., a privately-held biotechnology company developing modular protein therapeutics for autoimmune disease, today announced that company…
BOSTON, Mass.–(BUSINESS WIRE)–Entrada Therapeutics, Inc., a privately-held biotechnology company dedicated to transforming the treatment of devastating diseases through the development…
– Completed patient enrollment in Phase 3 clinical study of omidubicel; Topline data expected in the second quarter of 2020…
Funding to support the Aria CV Pulmonary Hypertension System Feasibility Study Financing led by Xeraya Capital ST. PAUL, Minn.–(BUSINESS WIRE)–Aria…